The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
HMGB1 release and redox regulates autophagy and apoptosis in cancer cells
Open accessAbstract
The functional relationship and cross-regulation between autophagy and apoptosis is complex. In this study we show that the high-mobility group box 1 protein (HMGB1) is a redox-sensitive regulator of the balance between autophagy and apoptosis. In cancer cells, anticancer agents enhanced autophagy and apoptosis, as well as HMGB1 release. HMGB1 release may be a prosurvival signal for residual cells after various cytotoxic cancer treatments. Diminished HMGB1 by short hairpin RNA transfection or inhibition of HMGB1 release by ethyl pyruvate or other small molecules led predominantly to apoptosis and decreased autophagy in stressed cancer cells. In this setting, reducible HMGB1 binds to the receptor for advanced glycation end products (RAGEs), but not to Toll-like receptor 4, induces Beclin1-dependent autophagy and promotes tumor resistance to alkylators (melphalan), tubulin disrupting agents (paclitaxel), DNA crosslinkers (ultraviolet light) and DNA intercalators (oxaliplatin or adriamycin). On the contrary, oxidized HMGB1 increases the cytotoxicity of these agents and induces apoptosis mediated by the caspase-9/-3 intrinsic pathway. HMGB1 release, as well as its redox state, thus links autophagy and apoptosis, representing a suitable target when coupled with conventional tumor treatments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“That said, it should be noted that biological activities of HMGB1 may flip from pro-inflammatory to anti-inflammatory depending on multiple variables including its oxidation state [917–923].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [920]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pankiv, S., Clausen, T. H., Lamark, T., Brech, A., Bruun, J.-A., Outzen, H., Øvervatn, A., Bjørkøy, G., & Johansen, T. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702824200 · Cited by 4,578
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
Scaffidi, P., Misteli, T., & Bianchi, M. E. (2002) · Nature · doi:10.1038/nature00858 · Cited by 4,221
Self-eating and self-killing: crosstalk between autophagy and apoptosis
Maiuri, M. C., Zalckvar, E., Kimchi, A., & Kroemer, G. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2239 · Cited by 3,638
Bcl-2 Antiapoptotic Proteins Inhibit Beclin 1-Dependent Autophagy
Pattingre, S., Tassa, A., Qu, X., Garuti, R., Liang, X. H., Mizushima, N., Packer, M., Schneider, M. D., & Levine, B. (2005) · Cell · doi:10.1016/j.cell.2005.07.002 · Cited by 3,536
Self-citationHMG-1 as a Late Mediator of Endotoxin Lethality in Mice
Wang, H., Bloom, O., Zhang, M., Vishnubhakat, J. M., Ombrellino, M., Che, J., Frazier, A., Yang, H., Ivanova, S., Borovikova, L. V., et al. (1999) · Science · doi:10.1126/science.285.5425.248 · Cited by 3,386
Self-citationApetoh, L., Ghiringhelli, F., Tesniere, A., Obeid, M., Ortiz, C., Criollo, A., Mignot, G., Maiuri, M. C., Ullrich, E., Saulnier, P., et al. (2007) · Nature Medicine · doi:10.1038/nm1622 · Cited by 3,056 · cited 2×
“For example, if dying tumor cells release the immune modulator HMGB1 following treatment, they can activate a TLR4-dependent tumor-specific immune response that enhances the effectiveness of the initial treatment (Apetoh et al., 2007).”
BackgroundHow to Interpret LC3 Immunoblotting
Mizushima, N., & Yoshimori, T. (2007) · Autophagy · doi:10.4161/auto.4600 · Cited by 2,595 · cited 2×
“Microtubule-associated protein light chain 3 (LC3) is now widely used as a marker to monitor autophagy (Mizushima and Yoshimori, 2007).”
BackgroundMethodHigh-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal
Lotze, M. T., & Tracey, K. J. (2005) · Nature reviews. Immunology · doi:10.1038/nri1594 · Cited by 2,490
Self-citationAutophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis
Degenhardt, K., Mathew, R., Beaudoin, B., Bray, K., Anderson, D., Chen, G., Mukherjee, C., Shi, Y., Gélinas, C., Fan, Y., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.06.001 · Cited by 2,069
Autophagy Suppresses Tumorigenesis through Elimination of p62
Mathew, R., Karp, C. M., Beaudoin, B., Vuong, N., Chen, G., Chen, H.-Y., Bray, K., Reddy, A., Bhanot, G., Gélinas, C., et al. (2009) · Cell · doi:10.1016/j.cell.2009.03.048 · Cited by 1,774
Flagged first, then by citations
Cited by
Sorted by citations
Galluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P., Alnemri, E. S., Altucci, L., Amelio, I., Andrews, D. W., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0012-4 · Cited by 6,680
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
Klionsky, D. J., Abdelmohsen, K., Abe, A., Abedin, M. J., Abeliovich, H., Acevedo Arozena, A., Adachi, H., Adams, C. M., Adams, P. D., Adeli, K., et al. (2016) · Autophagy · doi:10.1080/15548627.2015.1100356 · Cited by 5,894
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1
Klionsky, D. J., Abdel-Aziz, A. K., Abdelfatah, S., Abdellatif, M., Abdoli, A., Abel, S., Abeliovich, H., Abildgaard, M. H., Abudu, Y. P., Acevedo-Arozena, A., et al. (2021) · Autophagy · doi:10.1080/15548627.2020.1797280 · Cited by 2,897
Self-citationThe Beclin 1 network regulates autophagy and apoptosis
Kang, R., Zeh, H. J., Lotze, M. T., & Tang, D. (2011) · Cell Death & Differentiation · doi:10.1038/cdd.2010.191 · Cited by 2,485
Self-citationROS and the DNA damage response in cancer
Srinivas, U. S., Tan, B. W. Q., Vellayappan, B. A., & Jeyasekharan, A. D. (2019) · Redox Biology · doi:10.1016/j.redox.2018.101084 · Cited by 2,144
Feig, C., Jones, J. O., Kraman, M., Wells, R. J. B., Deonarine, A., Chan, D. S., Connell, C. M., Roberts, E. W., Zhao, Q., Caballero, O. L., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1320318110 · Cited by 2,100
PAMP s and DAMP s: signal 0s that spur autophagy and immunity
Tang, D., Kang, R., Coyne, C. B., Zeh, H. J., & Lotze, M. T. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01146.x · Cited by 1,327
Self-citationKang, R., Chen, R., Zhang, Q., Hou, W., Wu, S., Cao, L., Huang, J., Yu, Y., Fan, X.-G., Yan, Z., et al. (2014) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2014.05.001 · Cited by 956
Self-citationEndogenous HMGB1 regulates autophagy
Tang, D., Kang, R., Livesey, K. M., Cheh, C.-W., Farkas, A., Loughran, P., Hoppe, G., Bianchi, M. E., Tracey, K. J., Zeh, H. J., et al. (2010) · Journal of Cell Biology · doi:10.1083/jcb.200911078 · Cited by 951
Self-citationPrinciples and Current Strategies for Targeting Autophagy for Cancer Treatment
Amaravadi, R. K., Lippincott‐Schwartz, J., Yin, X., Weiss, W. A., Takebe, N., Timmer, W. C., DiPaola, R. S., Lotze, M. T., & White, E. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2634 · Cited by 912
Self-citationConsensus guidelines for the detection of immunogenic cell death
Kepp, O., Senovilla, L., Vitale, I., Vacchelli, E., Adjemian, S., Agostinis, P., Apetoh, L., Aranda, F., Barnaba, V., Bloy, N., et al. (2014) · OncoImmunology · doi:10.4161/21624011.2014.955691 · Cited by 832
Autophagy-Dependent Ferroptosis: Machinery and Regulation
Liu, J., Kuang, F., Kroemer, G., Klionsky, D. J., Kang, R., & Tang, D. (2020) · Cell chemical biology · doi:10.1016/j.chembiol.2020.02.005 · Cited by 819
Self-citationHydrogen peroxide – production, fate and role in redox signaling of tumor cells
Lennicke, C., Rahn, J., Lichtenfels, R., Wessjohann, L. A., & Seliger, B. (2015) · Cell Communication and Signaling · doi:10.1186/s12964-015-0118-6 · Cited by 593
Autophagy and apoptosis: where do they meet?
Mukhopadhyay, S., Panda, P. K., Sinha, N., Das, D. N., & Bhutia, S. K. (2014) · APOPTOSIS · doi:10.1007/s10495-014-0967-2 · Cited by 583
Yang, H., Antoine, D. J., Andersson, U., & Tracey, K. J. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.1212662 · Cited by 542
Self-citationCellular signalling of the receptor for advanced glycation end products (RAGE)
Xie, J., Méndez, J. D., Méndez-Valenzuela, V., & Aguilar-Hernández, M. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.06.013 · Cited by 525
HMGB1 in Cancer: Good, Bad, or Both?
Kang, R., Zhang, Q., Zeh, H. J., Lotze, M. T., & Tang, D. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0495 · Cited by 505
Self-citationDamage-associated molecular patterns in cancer: a double-edged sword
Hernandez, C., Huebener, P., & Schwabe, R. F. (2016) · Oncogene · doi:10.1038/onc.2016.104 · Cited by 506
High-Mobility Group Box 1, Oxidative Stress, and Disease
Tang, D., Kang, R., Zeh, H. J., & Lotze, M. T. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3356 · Cited by 475
Self-citationHMGB1, IL-1α, IL-33 and S100 proteins: dual-function alarmins
Bertheloot, D., & Latz, E. (2017) · Cellular & Molecular Immunology · doi:10.1038/cmi.2016.34 · Cited by 455
Autophagy in tumour immunity and therapy
Xia, H., Green, D. R., & Zou, W. (2021) · Nature reviews. Cancer · doi:10.1038/s41568-021-00344-2 · Cited by 421
Free Radicals in Cross Talk Between Autophagy and Apoptosis
Kaminskyy, V. O., & Zhivotovsky, B. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5746 · Cited by 421
Maycotte, P., & Thorburn, A. M. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.11.2.14627 · Cited by 397
The multifunctional protein HMGB1: 50 years of discovery
Tang, D., Kang, R., Zeh, H. J., & Lotze, M. T. (2023) · Nature reviews. Immunology · doi:10.1038/s41577-023-00894-6 · Cited by 405
Self-citationMatsuzawa, Y., Hwang, S., & Cadwell, K. (2017) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042617-053253 · Cited by 384
The Role of HMGB1 in the Pathogenesis of Inflammatory and Autoimmune Diseases
Magna, M., & Pisetsky, D. S. (2014) · Molecular Medicine · doi:10.2119/molmed.2013.00164 · Cited by 358
Metal Drugs and the Anticancer Immune Response
Englinger, B., Pirker, C., Heffeter, P., Terenzi, A., Kowol, C. R., Keppler, B. K., & Berger, W. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00396 · Cited by 355
Tumor-Related Molecular Mechanisms of Oxaliplatin Resistance
Martinez‐Balibrea, E., Martínez‐Cardús, A., Ginés, A., de Porras, V. R., Moutinho, C., Layos, L., Manzano, J. L., Bugés, C., Bystrup, S., Esteller, M., et al. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0636 · Cited by 344
Activating autophagy to potentiate immunogenic chemotherapy and radiation therapy
Galluzzi, L., Bravo-San Pedro, J. M., Demaria, S., Formenti, S. C., & Kroemer, G. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.183 · Cited by 314
High-Mobility Group Box 1 Is Essential for Mitochondrial Quality Control
Tang, D., Kang, R., Livesey, K. M., Kroemer, G., Billiar, T. R., Houten, B. V., Zeh, H. J., & Lotze, M. T. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.04.008 · Cited by 303
Self-citationMany faces of DAMPs in cancer therapy
Krysko, O., Aaes, T. L., Bachert, C., Vandenabeele, P., & Krysko, D. V. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.156 · Cited by 309
Deretic, V. P. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.10.006 · Cited by 308
A comprehensive glossary of autophagy-related molecules and processes (2ndedition)
Klionsky, D. J., Baehrecke, E. H., Brumell, J. H., Chu, C. T., Codogno, P., Cuervo, A. M., Debnath, J., Deretic, V. P., Elazar, Z., Eskelinen, E., et al. (2011) · Autophagy · doi:10.4161/auto.7.11.17661 · Cited by 298
Lilienthal, I., & Herold, N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186885 · Cited by 300
Li, J., Liu, J., Zhou, Z., Wu, R., Chen, X., Yu, C., Stockwell, B. R., Kroemer, G., Kang, R., & Tang, D. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.adg3049 · Cited by 305
Self-citationFearon, D. T. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0002 · Cited by 288
Thorburn, A. M., Thamm, D. H., & Gustafson, D. L. (2014) · Molecular Pharmacology · doi:10.1124/mol.114.091850 · Cited by 290
Jia, C., Zhang, J., Chen, H. A., Zhuge, Y., Chen, H., Qian, F., Zhou, K., Niu, C., Wang, F., Qiu, H., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-2021-3 · Cited by 278
HMGB1 Promotes Drug Resistance in Osteosarcoma
Huang, J. X., Ni, J., Liu, K., Yu, Y. H., Xie, M., Kang, R., Vernon, P. J., Cao, L., & Tang, D. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-2001 · Cited by 279
Self-citationOxidative stress-mediated HMGB1 biology
Yan, Y. Q., Tang, D., & Kang, R. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00093 · Cited by 268
Self-citationp53/HMGB1 Complexes Regulate Autophagy and Apoptosis
Livesey, K. M., Kang, R., Vernon, P. J., Buchser, W., Loughran, P., Watkins, S. C., Zhang, L., Manfredi, J. J., Zeh, H. J., Li, L., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2291 · Cited by 270
Self-citationRAGE and TLRs: Relatives, friends or neighbours?
Ibrahim, Z. A., Armour, C. L., Phipps, S., & Sukkar, M. B. (2013) · Molecular Immunology · doi:10.1016/j.molimm.2013.07.008 · Cited by 263
HMGB1-induced autophagy promotes chemotherapy resistance in leukemia cells
Liu, L., Yang, M., Kang, R., Wang, Z., Zhao, Y., Yu, Y. H., Xie, M., Yin, X.-C., Livesey, K. M., Lotze, M. T., et al. (2010) · Leukemia · doi:10.1038/leu.2010.225 · Cited by 253
Self-citationHMGB1 as biomarker and drug target
Vénéreau, E., Leo, F. D., Mezzapelle, R., Careccia, G., Musco, G., & Bianchi, M. E. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.06.031 · Cited by 245
Yan, W., Chang, Y., Liang, X., Cardinal, J. S., Huang, H., Thorne, S. H., Monga, S. P., Geller, D. A., Lotze, M. T., & Tsung, A. (2012) · Hepatology · doi:10.1002/hep.25572 · Cited by 244
Self-citationKang, R., Tang, D., Schapiro, N. E., Loux, T., Livesey, K. M., Billiar, T. R., Wang, H., Houten, B. V., Lotze, M. T., & Zeh, H. J. (2013) · Oncogene · doi:10.1038/onc.2012.631 · Cited by 233
Self-citationRegulation of Tumor Progression by Programmed Necrosis
Lee, S. Y., Ju, M. K., Jeon, H. M., Jeong, E. K., Lee, Y. J., Kim, C. H., Park, H. G., Han, S. I., & Kang, H. S. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/3537471 · Cited by 238
Intracellular Hmgb1 Inhibits Inflammatory Nucleosome Release and Limits Acute Pancreatitis in Mice
Kang, R., Zhang, Q., Hou, W., Yan, Z., Chen, R., Bonaroti, J. W., Bansal, P., Billiar, T. R., Tsung, A., Wang, Q., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.12.015 · Cited by 213
Self-citationThe high mobility group box: the ultimate utility player of a cell
Malarkey, C. S., & Churchill, M. E. A. (2012) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2012.09.003 · Cited by 207
Strange attractors: DAMPs and autophagy link tumor cell death and immunity
Hou, W., Zhang, Q., Yan, Z., Chen, R., Zeh, H. J., Kang, R., Lotze, M. T., & Tang, D. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.493 · Cited by 199
Self-citationMechanisms of chemotherapy-induced behavioral toxicities
Vichaya, E. G., Chiu, G. S., Krukowski, K., Lacourt, T. E., Kavelaars, A., Dantzer, R., Heijnen, C. J., & Walker, A. K. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00131 · Cited by 197
Inflammatory signaling cascades and autophagy in cancer
Monkkonen, T., & Debnath, J. (2017) · Autophagy · doi:10.1080/15548627.2017.1345412 · Cited by 189
High‐mobility group box‐1 in sterile inflammation
Tsung, A., Tohme, S., & Billiar, T. R. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12276 · Cited by 187
Dying cell clearance and its impact on the outcome of tumor radiotherapy
Lauber, K., Ernst, A., Orth, M., i, M. H., & Belka, C. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00116 · Cited by 200
The interplay between autophagy and ROS in tumorigenesis
Kongara, S., & Karantza, V. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00171 · Cited by 186
Cell Death and DAMPs in Acute Pancreatitis
Kang, R., Lotze, M. T., Zeh, H. J., Billiar, T. R., & Tang, D. (2014) · Molecular Medicine · doi:10.2119/molmed.2014.00117 · Cited by 182
Self-citationDNA Damage Response and Autophagy: A Meaningful Partnership
Eliopoulos, A. G., Havaki, S., & Gorgoulis, V. G. (2016) · Frontiers in Genetics · doi:10.3389/fgene.2016.00204 · Cited by 169
Redox Modulation of HMGB1-Related Signaling
Janko, C., Filipović, M. R., Munoz, L. E., Schorn, C., Schett, G. A., Ivanović‐Burmazović, I., & i, M. H. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5179 · Cited by 171
Immunological Significance of HMGB1 Post-Translational Modification and Redox Biology
Kwak, M. S., Kim, H. S., Lee, B., Kim, Y. H., Son, M., & Shin, J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01189 · Cited by 167
Lycorine: A prospective natural lead for anticancer drug discovery
Roy, M., Liang, L., Xiao, X., Feng, P., Ye, M., & Liu, J. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.07.147 · Cited by 165
Fibroblast-derived CXCL12 promotes breast cancer metastasis by facilitating tumor cell intravasation
Ahirwar, D. K., Nasser, M. W., Ouseph, M. M., Elbaz, M., Cuitiño, M. C., Kladney, R. D., Varikuti, S., Kaul, K., Satoskar, A. R., Ramaswamy, B., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0263-7 · Cited by 162
Demoulin, S., Herfs, M. F., Delvenne, P., & Hubert, P. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0812397 · Cited by 170
Inhibiting Systemic Autophagy during Interleukin 2 Immunotherapy Promotes Long-term Tumor Regression
Liang, X., de Vera, M. E., Buchser, W., Chavez, A. R. D. V., Loughran, P., Stolz, D. B., Basse, P. H., Wang, T., Houten, B. V., Zeh, H. J., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0320 · Cited by 158
Self-citationEat-Me: Autophagy, Phagocytosis, and Reactive Oxygen Species Signaling
Vernon, P. J., & Tang, D. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4810 · Cited by 161
Self-citationHuang, C.-Y., Chiang, S., Chen, W. T., Ke, T., Chen, T.-W., You, Y., Lin, C., Chao, K. S. C., & Huang, C. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-1019-6 · Cited by 155
Autophagy: An Emerging Immunological Paradigm
Deretic, V. P. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102108 · Cited by 158
Lü, B., Wang, C., Wang, M., Li, W., Chen, F., Tracey, K. J., & Wang, H. (2014) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2014.909730 · Cited by 153
Self-citationLocation is the key to function: HMGB1 in sepsis and trauma-induced inflammation
Deng, M., Scott, M. J., Fan, J., & Billiar, T. R. (2019) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mir1218-497r · Cited by 153
Mokarram, P., Albokashy, M., Zarghooni, M., Moosavi, M. A., Sepehri, Z., Chen, Q. M., Hudecki, A., Sargazi, A., Alizadeh, J., Moghadam, A. R., et al. (2017) · Autophagy · doi:10.1080/15548627.2017.1290751 · Cited by 150
Gut mucosal DAMPs in IBD: from mechanisms to therapeutic implications
Boyapati, R. K., Rossi, A. G., Satsangi, J., & Ho, G. (2016) · Mucosal Immunology · doi:10.1038/mi.2016.14 · Cited by 150
Targeting autophagy in prostate cancer: preclinical and clinical evidence for therapeutic response
Ashrafizadeh, M., Paskeh, M. D. A., Mirzaei, S., Gholami, M. H., Zarrabi, A., Hashemi, F., Hushmandi, K., Hashemi, M., Nabavi, N., Crea, F., et al. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02293-6 · Cited by 150
Arab, H. H., Al‐Shorbagy, M. Y., & Saad, M. A. (2021) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2021.109368 · Cited by 148
HMGB1-mediated autophagy promotes docetaxel resistance in human lung adenocarcinoma
Pan, B., Chen, D., Huang, J., Wang, R., Feng, B. C., Song, H., & Chen, L. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-165 · Cited by 147
DAMPs, ageing, and cancer: The ‘DAMP Hypothesis’
Huang, J., Xie, Y., Sun, X., Zeh, H. J., Kang, R., Lotze, M. T., & Tang, D. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2014.10.004 · Cited by 144
Self-citationHigh Mobility Group Box 1 (HMGB1) Activates an Autophagic Response to Oxidative Stress
Tang, D., Kang, R., Livesey, K. M., Zeh, H. J., & Lotze, M. T. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3666 · Cited by 146
Self-citationStress-induced cellular responses in immunogenic cell death: Implications for cancer immunotherapy
Radogna, F., & Diederich, M. F. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.02.006 · Cited by 146
Zhang, Q., Kang, R., Zeh, H. J., Lotze, M. T., & Tang, D. (2013) · Autophagy · doi:10.4161/auto.23691 · Cited by 145
Self-citationSecretory autophagy machinery and vesicular trafficking are involved in HMGB1 secretion
Kim, Y. H., Kwak, M. S., Lee, B., Shin, J. M., Aum, S., Park, I. H., Lee, M. G., & Shin, J. (2020) · Autophagy · doi:10.1080/15548627.2020.1826690 · Cited by 141
Wang, Z., Cao, L., Kang, R., Yang, M., Liu, L., Zhao, Y., Yu, Y., Xie, M., Yin, X.-C., Livesey, K. M., et al. (2011) · Autophagy · doi:10.4161/auto.7.4.14397 · Cited by 140
Self-citationAutophagy modulation for cancer therapy
Yang, Z. J., Chee, C. E., Huang, S., & Sinicrope, F. A. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.11.2.14663 · Cited by 140
Ren, Y., Wang, R., Weng, S., Xu, H., Zhang, Y., Chen, S., Liu, S., Ba, Y., Zhou, Z., Luo, P., et al. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01831-w · Cited by 149
The role of high mobility group box 1 (HMGB1) in the pathogenesis of kidney diseases
Chen, Q., Guan, X., Zuo, X., Wang, J., & Yin, W. (2016) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2016.02.004 · Cited by 137
Mechanisms of Resistance to Conventional Therapies for Osteosarcoma
Marchandet, L., Lallier, M., Charrier, C., Baud’huin, M., Ory, B., & Lamoureux, F. (2021) · Cancers · doi:10.3390/cancers13040683 · Cited by 142
MIR34Aregulates autophagy and apoptosis by targetingHMGB1in the retinoblastoma cell
Liu, K., Huang, J. X., Xie, M., Yu, Y. H., Zhu, S., Kang, R., Cao, L., Tang, D., & Duan, X. (2014) · Autophagy · doi:10.4161/auto.27418 · Cited by 137
Self-citationGebremeskel, S., & Johnston, B. (2015) · Oncotarget · doi:10.18632/oncotarget.6113 · Cited by 139
AGE-RAGE synergy influences programmed cell death signaling to promote cancer
Waghela, B. N., Vaidya, F. U., Ranjan, K., Chhipa, A. S., Tiwari, B. S., & Pathak, C. (2020) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-020-03928-y · Cited by 135
Transient and Local Expression of Chemokine and Immune Checkpoint Traps To Treat Pancreatic Cancer
Miao, L., Li, J., Liu, Q., Feng, R., Das, M., Lin, C. M., Goodwin, T. J., Dorosheva, O., Liu, R., & Huang, L. (2017) · ACS Nano · doi:10.1021/acsnano.7b01786 · Cited by 132
Emerging Role of High-Mobility Group Box 1 (HMGB1) in Liver Diseases
Chen, R., Hou, W., Zhang, Q., Kang, R., Fan, X., & Tang, D. (2013) · Molecular Medicine · doi:10.2119/molmed.2013.00099 · Cited by 130
Self-citationZhang, Y., Cheng, Y., Ren, X., Zhang, L., Yap, K. L., Wu, H., Patel, R., Liu, D., Qin, Z.-H., Shih, I., et al. (2011) · Oncogene · doi:10.1038/onc.2011.290 · Cited by 128
Emerging Roles for HMGB1 Protein in Immunity, Inflammation, and Cancer
Ranzato, E., Martinotti, S., & Patrone, M. (2015) · ImmunoTargets and Therapy · doi:10.2147/itt.s58064 · Cited by 127
Redox signaling: Potential arbitrator of autophagy and apoptosis in therapeutic response
Zhang, L., Wang, K., Lei, Y., Li, Q., Nice, E. C., & Huang, C. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.08.030 · Cited by 127
Autophagy and inflammatory diseases
Jones, S. A., Mills, K. H. G., & Harris, J. (2013) · Immunology and Cell Biology · doi:10.1038/icb.2012.82 · Cited by 127
Adaptive immunity after cell death
Zelenay, S., & Sousa, C. R. E. (2013) · Trends in Immunology · doi:10.1016/j.it.2013.03.005 · Cited by 129
The Role of High Mobility Group Box 1 in Innate Immunity
Lee, S.-A., Kwak, M. S., Kim, S., & Shin, J. (2014) · Yonsei Medical Journal · doi:10.3349/ymj.2014.55.5.1165 · Cited by 123
Immunogenic Cell Death: Can It Be Exploited in PhotoDynamic Therapy for Cancer?
Panzarini, E., Inguscio, V., & Dini, L. (2012) · BioMed Research International · doi:10.1155/2013/482160 · Cited by 120
Tumor immunity times out: TIM-3 and HMGB1
Tang, D., & Lotze, M. T. (2012) · Nature Immunology · doi:10.1038/ni.2396 · Cited by 116
Self-citationAntonopoulos, C. H., Sanadi, C. E. E., Kaiser, W. J., Mocarski, E. S., & Dubyak, G. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300645 · Cited by 115
The beclin 1 interactome: Modification and roles in the pathology of autophagy-related disorders
Kaur, S., & Changotra, H. (2020) · Biochimie · doi:10.1016/j.biochi.2020.04.025 · Cited by 116
A Janus Tale of Two Active High Mobility Group Box 1 (HMGB1) Redox States
Tang, D., Billiar, T. R., & Lotze, M. T. (2012) · Molecular Medicine · doi:10.2119/molmed.2012.00314 · Cited by 112
Self-citationDerer, A., Deloch, L., Rubner, Y., Fietkau, R., Frey, B., & Gaipl, U. S. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00505 · Cited by 113
Metadata
- Authors
- Tang, D., Kang, R., Cheh, C.-W., Livesey, K. M., Liang, X., Schapiro, N. E., Benschop, R., Sparvero, L. J., Amoscato, A. A., Tracey, K. J., Zeh, H. J., & Lotze, M. T.
- Affiliations
- University of Pittsburgh (US)
- Eli Lilly (United States) (US)
- North Shore University Hospital (US)
- Corresponding author
- Tang, D
- Zeh, H J
- Lotze, M T
- Venue
- Oncogene
- Published
- 2010-07-12
- Volume
- 29
- Issue
- 38
- Pages
- 5299-5310
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- PMC
- PMC2945431
- OpenAlex
- W2052094075
- Cited by
- 461
- References
- 49
- Citations by year
- 2026: 10 · 2025: 16 · 2024: 12 · 2023: 20 · 2022: 27 · 2021: 33 · 2020: 32 · 2019: 26 · 2018: 36 · 2017: 28 · 2016: 28 · 2015: 33 · 2014: 47 · 2013: 44 · 2012: 35
- FWCI
- 22.49
- Type
- journal article
- Language
- en
- Update notices
- correction (2025-07-24)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- University of Pittsburgh
- National Institutes of Health
- National Cancer Institute (P01CA101944)
- National Institute of General Medical Sciences (R01GM062508)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Keywords
- HMGB1, HMGB1 release, redox regulation, autophagy, apoptosis, cancer cells, RAGE, Beclin-1, ethyl pyruvate, chemoresistance, alkylating agents, paclitaxel, oxaliplatin, doxorubicin, ultraviolet radiation, caspase-9, caspase-3, mitochondrial apoptosis
- MeSH terms
- Antineoplastic Agents, Autophagy, Neoplasms, Oxidation-Reduction, Apoptosis, HMGB1 Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
